Please assess the completion status of the following clinical trial:

Trial Title: Multi-Centre Trial Comparing Three Artemisinin-Based Combination Treatments on P. Falciparum Malaria

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: PHASE3
- Number of Arms: None

Eligibility Criteria:
Inclusion Criteria:~* age at least 6 months,~* weight at least 5 kg,~* residing in one of the four countries (Mali, Cameroon, Sudan, Rwanda),~* able to receive oral treatment,~* having an axillary body temperature of more than 37,5 degrees Celsius or history of fever within the proceeding 24 hours,~* suffering from a mono specific P. falciparum infection with a parasite density between 2000 and 200000 asexual forms per micro litre of blood.~Exclusion Criteria:~* presence of severe or complicated malaria (WHO 2000),~* severe concomitant pathology or one that needs a medical follow-up incompatible with the study,~* allergic to one of the drugs involved in this study,~* pregnant (reported pregnancy, detected clinically or with the β HCG test),~* use of one of the anti-malaria drugs involved in this study during 28 days preceding inclusion.

- Gender: ALL
- Minimum Age: 6 Months
- Maximum Age: None
- Healthy Volunteers: f

Based on this trial design, predict the completion outcome and termination type (if applicable).